XML 119 R101.htm IDEA: XBRL DOCUMENT v3.10.0.1
Subsequent Events - Additional Information (Detail) - Subsequent Event [Member] - Myonexus Therapeutics, Inc. [Member]
$ in Millions
Feb. 27, 2019
USD ($)
Subsequent Event [Line Items]  
Final exercise price $ 165.0
Additional development milestone payments to be paid $ 200.0